 valu class IC drug acut convers paroxysm atrial fibril flutter rhythm single-blind random studi efficaci safeti intraven propafenon mg/kg bodi min versu flecainid mg/kg min patient atrial fibril flutter treatment success sinu rhythm convers patient atrial fibril propafenon atrial fibril flecainid atrial fibril present equal convers rhythm patient propafenon group flecainid group atrial flutter patient propafenon flecainid NS mean time convers min propafenon group min flecainid group NS qr lengthen ms patient flecainid propafenon plasma level arrhythmia rhythm transient advers effect frequent flecainid group propafenon group conclus dose mg/kg min flecainid effect propafenon convers paroxysm atrial fibril rhythm propafenon plasma level advers effect dose infus rate propafenon group suffici optim effect drug effect patient atrial flutter